YAKUGAKU ZASSHI
Online ISSN : 1347-5231
Print ISSN : 0031-6903
ISSN-L : 0031-6903
総説
新睡眠薬及び睡眠薬拮抗物質の探索研究から睡眠機構研究に辿りつくまで —バルビツール酸からウリジンまで(その1)1)
山本 郁男
著者情報
ジャーナル フリー

2005 年 125 巻 1 号 p. 73-120

詳細
抄録

  Thirty-six allyl substituted oxopyrimidine analogues such as barbituric acid (BA), barbiturates, uracil, thymine, and related derivatives including 13 new compounds were synthesized and their pharmacologic effects ([hypnotic activity, anticonvulsant activity against pentylentetrazol (PTZ)-induced seizures, and LD50]) and interactions with the barbiturates were evaluated in mice and rats. The results are briefly and parially summarized as follows. BA prolonged pentobarbital (PB)-induced sleep and had some central depressant effects. N,5,5-Triallyl-BA exhibited some hypnotic and anticonvulsant activities, although the other 5,N-allyl-compounds did not show any activity except for allobarbital (AlloB). N-Allyl-BA, 5-allyl-BA, N1,N3,5-triallyl-BA, N,5,5-triallyl-BA, and N1,N3,5,5-tetraallyl-BA also prolonged PB-induced sleep. Interestingly, N,5,5-triallyl-BA was the most potent in the interaction with AlloB, phenobarbital (PheB), amobarbital (AB), PB, and thiopental (TP) but not barbital (B). N1,N3,5,5-Tetraallyl-BA prolonged AlloB-, PB-, and AB-induced sleep but not B-, PheB-, and TP-induced sleep. N1,N3,5-Triallyl-B prolonged only PB- and TP-induced sleep. 5,5-Diallyl-BA prolonged PheB- and TP-induced sleep. N,5-Diallyl-BA prolonged only TP-induced sleep. In contrast, BA and N1,N3,5-triallyl-AB tended to antagonize AlloB, AB, and B. N1,N3,5,5-Tetraallyl-BA also slightly antagonized B, PheB, and TP. 5,5-Diallyl-BA antagonized only AB. The prolonging effects of BA, N,5,5-triallyl-BA, and N1,N3,5,5-tetraallyl-BA on PB-induced sleep were dose dependent. These results indicate that the position and number of allyl groups substituted on the structure of BA play an important role in their depressant activities. This review deals with the structure-activity relationship of allyl-substituted oxopyrimidines as part of our search for antagonists and agonists of barbiturates as well as their mechanisms of action.

著者関連情報
© 2005 by the PHARMACEUTICAL SOCIETY OF JAPAN
前の記事 次の記事
feedback
Top